about
The HAC1 gene from Pichia pastoris: characterization and effect of its overexpression on the production of secreted, surface displayed and membrane proteinsDopamine D4 receptor oligomerization--contribution to receptor biogenesisFolding efficiency is rate-limiting in dopamine D4 receptor biogenesisBTB Protein KLHL12 targets the dopamine D4 receptor for ubiquitination by a Cul3-based E3 ligaseStructural insights into the extracellular assembly of the hematopoietic Flt3 signaling complexInfluence of the antipsychotic drug pipamperone on the expression of the dopamine D4 receptorKLHL12 Promotes Non-Lysine Ubiquitination of the Dopamine Receptors D4.2 and D4.4, but Not of the ADHD-Associated D4.7 VariantHow the venom from the ectoparasitoid Wasp nasonia vitripennis exhibits anti-inflammatory properties on mammalian cell lines.RhoBTB3 interacts with the 5-HT7a receptor and inhibits its proteasomal degradation.Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives.The serotonin 5-HT7 receptors: two decades of research.Extracellular complexes of the hematopoietic human and mouse CSF-1 receptor are driven by common assembly principles.Role of glucocorticoids in dopamine-related neuropsychiatric disorders.On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulationSelective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems.The dopamine D4 receptor: biochemical and signalling properties.GPCR oligomerization: contribution to receptor biogenesis.Role of dimerization in dopamine D(4) receptor biogenesis.Dopamine D4 receptor ubiquitination.KLHL12-mediated ubiquitination of the dopamine D4 receptor does not target the receptor for degradation.Cooperation of NFkappaB and CREB to induce synergistic IL-6 expression in astrocytes.Resistance of the dopamine D4 receptor to agonist-induced internalization and degradation.Cloning, genomic organization and functionality of 5-HT(7) receptor splice variants from mouse brain.Orientation-dependent gene expression with Epstein-Barr virus-derived vectors.Downregulation of 5-HT7 Serotonin Receptors by the Atypical Antipsychotics Clozapine and Olanzapine. Role of Motifs in the C-Terminal Domain and Interaction with GASP-1.Inducible production of recombinant human Flt3 ectodomain variants in mammalian cells and preliminary crystallographic analysis of Flt3 ligand-receptor complexes.Dopamine D₄ receptor counteracts morphine-induced changes in µ opioid receptor signaling in the striosomes of the rat caudate putamen.Regulation of G Protein-Coupled Receptors by Ubiquitination.Detection of G protein-coupled receptor (GPCR) dimerization by coimmunoprecipitation.Dopamine receptor D4 internalization requires a beta-arrestin and a visual arrestin.Characterization of Antibodies to Identify Cellular Expression of Dopamine Receptor 4.Molecular dissection of the human A3 adenosine receptor coupling with β-arrestin2.Dopamine D4 receptor stimulation prevents nigrostriatal dopamine pathway activation by morphine: relevance for drug addiction.Design, synthesis and biological evaluation of novel bivalent ligands targeting Dopamine D2-like receptors and µ opioid receptor.Biochemical and pharmacological study of N-linked glycosylation of the human serotonin 5-HT₇a receptor.
P50
Q21246019-C3AAB448-1F67-45E3-9E2C-836BAE2CE100Q24293127-1B3E05B7-28A1-46EE-B9AD-55F5066684F1Q24297696-D7773C13-D293-4000-B9CA-7349835895CDQ24652896-E02D5DB1-696C-4335-8AD8-252DB3288658Q27666909-6FECBCA0-FA16-43E0-9486-46871440B321Q28263992-D1A99B9C-E08F-49AB-82FD-BEA41DC7FBFDQ28553030-4133264A-B8D3-4998-8CB2-2F8F6A923FE4Q33599721-3CC9C0DD-40B2-4C9A-9EE3-7C0717DF1E08Q34127680-71875C87-8653-4A8D-81E8-78EC8A5CE7A0Q34172419-127C7A2D-650B-46EA-A5D3-EB65288517F5Q34371660-A4DDC7F7-D4D9-4FDB-8653-EA4368C85ADDQ35678362-3FF4FD27-C441-4F07-9BD3-8A3881280044Q36323821-7870A2A1-590C-4F87-BEFD-CE79348F55ACQ37061890-99A503E2-A606-4F0C-ABD3-4FB2A8EE37A7Q37090669-249224E4-0405-44FC-93E6-07068CAB266CQ37694353-2B0D5938-DFBB-4B08-AA69-18FADBCE7F74Q38060603-FCAA309B-D18E-473A-B6E4-E316B83AEC22Q38245070-EABDE5A3-C3AC-4BF0-BC16-D646DB8A3A64Q38805863-34BB0AB7-1BAD-4D0E-A0A4-6B7F5CD84164Q39748131-57A25B42-D088-466C-A471-EC1C45B3FE56Q39748137-F76114C0-698F-44DF-ADEC-641B7C325B07Q39771815-D3743FBC-E6FD-4BF3-AA2D-7BD0EE2B5DA3Q39939683-13ECCF30-FB36-4F34-973F-0D2561605B6AQ40607399-3B49E703-F99D-49C5-93BF-461781ED6625Q41368179-8090BDC7-3289-42E5-BBE4-CAD0D51069BDQ41855810-880A5866-59E4-4E74-9297-1A7D120C78E0Q41902104-9DAF5CF6-D1B1-4608-8137-03E1D3A4A4DEQ42009313-8DD3E5C2-076D-4115-B309-A9515E42A811Q44600844-B4E38D8C-E8AA-492E-8D4A-1C32727CC9A1Q45265690-ECE9D024-A638-4158-864A-9B5F5CB33738Q45299671-D712B3EF-3B34-42E7-B4D5-FB59A9DE808BQ47224621-578C8FBF-93C2-46E4-8FEC-A9F8C9F18838Q48018826-AA3C8715-B587-436D-881F-1FD95537C0A9Q49024094-5BDD38EC-5672-40D6-A3B3-0218CCDCBC0DQ49029261-E24E6023-B2CD-4987-BB1F-A8EA127649A9
P50
name
Kathleen Van Craenenbroeck
@ast
Kathleen Van Craenenbroeck
@en
Kathleen Van Craenenbroeck
@es
Kathleen Van Craenenbroeck
@nl
type
label
Kathleen Van Craenenbroeck
@ast
Kathleen Van Craenenbroeck
@en
Kathleen Van Craenenbroeck
@es
Kathleen Van Craenenbroeck
@nl
prefLabel
Kathleen Van Craenenbroeck
@ast
Kathleen Van Craenenbroeck
@en
Kathleen Van Craenenbroeck
@es
Kathleen Van Craenenbroeck
@nl